Computational Fragment-Based Drug Design: Current Trends, Strategies, and Applications
Fragment-based drug design (FBDD) has become an effective methodology for drug development for decades. Successful applications of this strategy brought both opportunities and challenges to the field of Pharmaceutical Science. Recent progress in the computational fragment-based drug design provide an additional approach for future research in a time- and labor-efficient manner. Combining multiple in silico methodologies, computational FBDD possesses flexibilities on fragment library selection, protein model generation, and fragments/compounds docking mode prediction. These characteristics provide computational FBDD superiority in designing novel and potential compounds for a certain target. The purpose of this review is to discuss the latest advances, ranging from commonly used strategies to novel concepts and technologies in computational fragment-based drug design. Particularly, in this review, specifications and advantages are compared between experimental and computational FBDD, and additionally, limitations and future prospective are discussed and emphasized.
KEY WORDSfragment-based drug design fragment database drug discovery fragment docking virtual screening
The authors would like to acknowledge the funding supports to the Xie laboratory from the NIH NIDA (P30 DA035778A1) and DOD (W81XWH-16-1-0490). The first author would like to thank Jie in particular, for the consistant support, love, and the memorable and solemn wedding. How lucky the first author is to have Jie as his bride!
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no competing interest.
- 25.Webb B, Sali A. Protein structure modeling with MODELLER. Protein Structure Prediction. 2014:1–15.Google Scholar
- 31.Speck-Planche A, Cordeiro MND. Fragment-based in silico modeling of multi-target inhibitors against breast cancer-related proteins. Mol Divers. 2017:1–13.Google Scholar
- 43.Damewood JR, Jr., Lerman CL, Masek BB. NovoFLAP: a ligand-based de novo design approach for the generation of medicinally relevant ideas. J Chem Inf Model 2010;50(7):1296–1303.Google Scholar